| 摘要 |
An aqueous formulation of argatroban and of related compounds is disclose d along with a reconstitutable formulation, each of which is substantially, if not totally alcohol free. The formulations are also substantially free, i f not totally free, of mono-, di-, and oligo- saccharides. An especially pre ferred embodiment is a ready-to-use 1 mg/ml injectable dosage form having ar gatroban, lactobionic acid, and methionine.
|
